C.S. Kim is associate medical director, Quality, Patient Safety, and Clinical Efficiency, University of Washington Medical Center, and associate professor, Division of General Internal Medicine, Department of Medicine, University of Washington School of Medicine, Seattle, Washington.
J.B. Lynch is medical director, Infection Prevention and Control, Harborview Medical Center, and associate professor, Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington School of Medicine, Seattle, Washington.
Acad Med. 2020 Aug;95(8):1146-1148. doi: 10.1097/ACM.0000000000003410.
On January 19, 2020, the first case of a patient with coronavirus disease 2019 (COVID-19) in the United States was reported in Washington State. On February 29, 2020, a patient infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) passed away in a hospital in Seattle-King County, the first reported COVID-19-related death in the United States. That same day, a skilled nursing and rehabilitation facility in the county reported that several of its residents tested positive for SARS-CoV-2 and that many staff had symptoms compatible with COVID-19.The University of Washington Medicine health system (UW Medicine), which is based in Seattle-King County and provides quaternary care for the region, was one of several health care organizations called upon to address this growing crisis. What ensued was a series of swiftly enacted decisions and activities at UW Medicine, in partnership with local, state, and national public health agencies, to respond to the COVID-19 pandemic. Tapping into the multipronged mission areas of academic medicine, UW Medicine worked to support the community, innovate in science and clinical practice; lead policy and practice guideline development; and adopt changes as the crisis unfolded. In doing so, health system leaders had to balance their commitments to students, residents and fellows, researchers, faculty, staff, and hospital and health center entities, while ensuring that patients continued to receive cutting-edge, high-quality, safe care. In this Invited Commentary, the authors highlight the work and challenges UW Medicine has faced in responding to the global COVID-19 pandemic.
2020 年 1 月 19 日，美国华盛顿州报告了首例 2019 年冠状病毒病（COVID-19）患者。2020 年 2 月 29 日，西雅图-金县的一家医院报告了首例因严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）感染而死亡的 COVID-19 患者。同日，该县的一家熟练护理和康复设施报告称，其数名居民的 SARS-CoV-2 检测呈阳性，许多工作人员出现了符合 COVID-19 的症状。位于西雅图-金县的华盛顿大学医学健康系统（UW Medicine）是应召应对这一日益严重的危机的几家医疗保健组织之一，为该地区提供四级护理。随后，UW Medicine 与当地、州和国家公共卫生机构合作，迅速做出了一系列决策和活动，以应对 COVID-19 大流行。UW Medicine 利用其学术医学的多方面使命领域，努力支持社区、在科学和临床实践中创新、领导政策和实践指南的制定，并在危机发展过程中进行变革。在这样做的过程中，医疗系统的领导者必须平衡他们对学生、住院医师和研究员、研究人员、教职员工以及医院和医疗中心实体的承诺，同时确保患者继续接受前沿、高质量、安全的护理。在这篇特邀评论中，作者强调了 UW Medicine 在应对全球 COVID-19 大流行方面所面临的工作和挑战。
